| Title | Sexuality and health-related quality of life after prostate cancer in African-American and white men treated for localized disease. | | Author(s) | Jenkins R, Schover LR, Fouladi RT, Warneke C, Neese L, Klein EA, Zippe C, Kupelian P | | Institution | Department of Behavioral Science, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. rljeffrie@mdanderson.org | | Source | J Sex Marital Ther 2004 Mar-Apr; 30(2):79-93. | | MeSH | Adult
African Americans
Aged
Aged, 80 and over
Attitude to Health
Comparative Study
European Continental Ancestry Group
Health Status
Humans
Impotence
Male
Middle Aged
Prostatectomy
Prostatic Neoplasms
Quality of Life
Radiotherapy, Adjuvant
Research Support, Non-U.S. Gov't
Risk Factors
Sexual Behavior
Stress, Psychological
Time Factors
United States
| | Abstract | The purpose of this study was to examine differences in sexual attitudes and quality of life of White and African-American men who have undergone radical prostatectomy or radiation therapy for localized prostate cancer. Respondents included 1,112 White and 118 African-American men. Response rates differed by race, with 51% of White men and 28% of African-American men returning the questionnaire assessing demographics, medical history, sexual functioning, attitudes about seeking help for sexual problems, sexual self-schema, and health-related quality of life. African Americans were more likely than Whites to have undergone radiation therapy (p <.0001) and were more likely to indicate that a desire to maintain sexual functioning influenced their treatment choice (p <.0001). African-American men also had more positive attitudes than did White men toward seeking help for sexual problems and were more likely to report seeking past help and intending to seek future help. African-American men reported more problems with sexual desire (p =.0003), although their sexual function scores did not differ significantly from those of Whites. African-American men may be more at risk for distress when prostate cancer treatment causes sexual dysfunction. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 14742098 |
|
